• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Community pharmacist-led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer.社区药剂师主导的电话随访能够对一名转移性乳腺癌门诊患者的依维莫司所致不良事件进行密切管理。
Can Pharm J (Ott). 2017 Sep 22;150(6):362-365. doi: 10.1177/1715163517732088. eCollection 2017 Nov-Dec.
2
Everolimus in Breast Cancer: The Role of the Pharmacist.依维莫司在乳腺癌中的应用：药剂师的作用。
Ann Pharmacother. 2014 Sep;48(9):1194-1201. doi: 10.1177/1060028014542415. Epub 2014 Jul 9.
3
Impact of pharmacist-led medication management in care transitions.药师主导的药物管理在护理转接中的影响。
BMC Health Serv Res. 2017 Nov 13;17(1):722. doi: 10.1186/s12913-017-2684-3.
4
Occurrence and characterization of everolimus adverse events during first and subsequent cycles in the treatment of metastatic breast cancer.转移性乳腺癌治疗首个周期及后续周期中依维莫司不良事件的发生情况与特征
Support Care Cancer. 2016 Jul;24(7):2913-8. doi: 10.1007/s00520-016-3105-6. Epub 2016 Feb 4.
5
Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial.地塞米松漱口液（SWISH）预防激素受体阳性、HER2 阴性转移性乳腺癌女性患者接受依维莫司相关口腔炎：一项单臂、2 期试验。
Lancet Oncol. 2017 May;18(5):654-662. doi: 10.1016/S1470-2045(17)30109-2. Epub 2017 Mar 15.
6
Targeting the mammalian target of rapamycin pathway with everolimus: implications for the management of metastatic breast cancer.使用依维莫司靶向雷帕霉素哺乳动物靶点：对转移性乳腺癌管理的意义。
J Oncol Pharm Pract. 2015 Dec;21(6):433-42. doi: 10.1177/1078155214540732. Epub 2014 Jun 25.
7
Real-World Analysis of Medical Costs and Healthcare Resource Utilization in Elderly Women with HR+/HER2- Metastatic Breast Cancer Receiving Everolimus-Based Therapy or Chemotherapy.对接受依维莫司治疗或化疗的HR+/HER2-转移性乳腺癌老年女性的医疗成本和医疗资源利用的真实世界分析。
Adv Ther. 2016 Jun;33(6):983-97. doi: 10.1007/s12325-016-0328-3. Epub 2016 May 23.
8
Overcoming the Adverse Effects of Everolimus to Achieve Maximum Efficacy in the Treatment of Inoperable Breast Cancer: A Review of 11 Cases at Our Hospital.克服依维莫司的不良反应以实现不可手术乳腺癌治疗的最大疗效：我院11例病例回顾
Case Rep Oncol. 2018 Jul 25;11(2):511-520. doi: 10.1159/000490787. eCollection 2018 May-Aug.
9
Pharmacist-led patient education and adverse event management in patients with non-small cell lung cancer receiving afatinib in a community-based, real-world clinical setting.在社区真实临床环境中，由药剂师主导对接受阿法替尼治疗的非小细胞肺癌患者进行患者教育及不良事件管理。
J Oncol Pharm Pract. 2020 Jan;26(1):13-22. doi: 10.1177/1078155219833441. Epub 2019 Mar 4.
10
Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Clinical Trial.依维莫司联合内分泌治疗用于雌激素受体阳性、人表皮生长因子受体 2 阴性的绝经后晚期乳腺癌：一项临床试验。
JAMA Oncol. 2018 Jul 1;4(7):977-984. doi: 10.1001/jamaoncol.2018.0060.

引用本文的文献

1
Pharmacists' knowledge, attitudes, beliefs, and barriers toward breast cancer health promotion: a cross-sectional study in the Palestinian territories.药剂师对乳腺癌健康促进的知识、态度、信念及障碍：巴勒斯坦地区的一项横断面研究
BMC Health Serv Res. 2021 May 6;21(1):429. doi: 10.1186/s12913-021-06458-5.
2
Oncology pharmacist contributions to treatment with oral anticancer agents in a Japanese community pharmacy setting.日本社区药房环境下肿瘤药师在口服抗癌药治疗中的贡献。
Can Pharm J (Ott). 2018 Oct 11;151(6):377-382. doi: 10.1177/1715163518802865. eCollection 2018 Nov-Dec.

本文引用的文献

1
Guidelines for outpatient cancer care by community pharmacists.社区药剂师的门诊癌症护理指南。
Can Pharm J (Ott). 2016 Dec 7;150(1):24-31. doi: 10.1177/1715163516680009. eCollection 2017 Jan-Feb.
2
The Nurse-Led Telephone Follow-Up on Medication and Dietary Adherence among Patients after Myocardial Infarction: A Randomized Controlled Clinical Trial.心肌梗死后患者药物和饮食依从性的护士主导电话随访：一项随机对照临床试验
Int J Community Based Nurs Midwifery. 2016 Jul;4(3):199-208.
3
Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice.雷帕霉素靶蛋白抑制剂所致口腔黏膜损伤：病理生物学新观点及其对临床实践的影响
Cancer Med. 2016 Aug;5(8):1897-907. doi: 10.1002/cam4.761. Epub 2016 Jun 23.
4
Evaluation of the role and usefulness of a pharmacist outpatient service for patients undergoing monotherapy with oral anti-cancer agents.评估药剂师门诊服务对接受口服抗癌药物单一疗法患者的作用和实用性。
J Oncol Pharm Pract. 2017 Sep;23(6):413-421. doi: 10.1177/1078155216655473. Epub 2016 Jun 20.
5
AntiC: A practice tool for the safe use of oral chemotherapeutics by community and hospital pharmacists.AntiC：社区和医院药剂师安全使用口服化疗药物的实践工具。
Can Pharm J (Ott). 2015 May;148(3):118-24. doi: 10.1177/1715163515578454.
6
Everolimus plus exemestane for the treatment of advanced breast cancer: a review of subanalyses from BOLERO-2.依维莫司联合依西美坦治疗晚期乳腺癌：BOLERO-2研究亚组分析综述
Neoplasia. 2015 Mar;17(3):279-88. doi: 10.1016/j.neo.2015.01.005.
7
Follow-up telephone calls to patients discharged after undergoing orthopaedic surgery: double-blind, randomised controlled trial of efficacy.骨科手术后出院患者的随访电话：疗效的双盲随机对照试验
J Clin Nurs. 2015 Oct;24(19-20):2736-44. doi: 10.1111/jocn.12795. Epub 2015 Feb 23.
8
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.绝经后激素受体阳性晚期乳腺癌患者中依维莫司相关不良事件的发生率及时间进程：来自BOLERO-2研究的见解
Ann Oncol. 2014 Apr;25(4):808-815. doi: 10.1093/annonc/mdu009. Epub 2014 Mar 10.
9
Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2.依维莫司联合依西美坦对比单用依西美坦治疗亚洲HER2阴性、激素受体阳性乳腺癌患者的疗效：BOLERO-2研究
Breast Cancer. 2014 Nov;21(6):703-14. doi: 10.1007/s12282-013-0444-8. Epub 2013 Feb 13.
10
Satisfaction with nurse-led telephone follow up for low to intermediate risk prostate cancer patients treated with radical radiotherapy. A comparative study.低危和中危前列腺癌根治性放疗患者接受护士主导的电话随访的满意度：一项对比研究。
Eur J Oncol Nurs. 2013 Apr;17(2):162-9. doi: 10.1016/j.ejon.2012.04.003. Epub 2012 May 17.

Community pharmacist-led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer.

作者信息

Yokoyama Satoshi, Yajima Satoko, Sakai Chihiro, Yamashita Shuji, Noguchi Yoshihiro, Ino Yoko, Iguchi Kazuhiro, Teramachi Hitomi

机构信息

Laboratory of Community Pharmacy (Yokoyama, Yajima, Sakai, Ino, Iguchi), Gifu Pharmaceutical University, Gifu, Japan.

出版信息

Can Pharm J (Ott). 2017 Sep 22;150(6):362-365. doi: 10.1177/1715163517732088. eCollection 2017 Nov-Dec.

DOI:10.1177/1715163517732088
PMID:29123595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5661674/
Abstract
摘要